Amazon.com, Inc. (AMZN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN)

AMZN 229.12

-0.2%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: H James Morris who wrote (84714)	11/20/1999 6:53:00 PM
From: Tom D	Read Replies (1) of 164684

There is considerable optimism built into the share price. I would take the profits and run, since horrendous competition will be emerging in this field. There are already over 2 dozen handheld prescription writing companies. Allscripts is ahead of some of them because they are offering an incremental revenue stream to physicians. But the whole problem is creating enough revenues to motivate doctors to embrace electronics, and to offset the tremendous time requirements for use of the devices. I expect there will be other companies who will create more compelling reasons for doctors to get wired than Allscripts can. In addition, while there are 750,000 doctors in the US, only a minority of them are candidates for the Allscripts prescription writer, due to prior alliances, and the structure of their medical groups. I am skeptical. Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next